| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Caveolin 1 | 12 | 2022 | 59 | 2.760 |
Why?
|
| Scleroderma, Systemic | 10 | 2017 | 446 | 1.710 |
Why?
|
| Heart | 13 | 2021 | 850 | 1.440 |
Why?
|
| Fibroblasts | 13 | 2022 | 902 | 0.950 |
Why?
|
| Lung | 10 | 2016 | 849 | 0.930 |
Why?
|
| Lung Diseases, Interstitial | 4 | 2014 | 110 | 0.920 |
Why?
|
| Proteoglycans | 16 | 2007 | 103 | 0.890 |
Why?
|
| Monocytes | 7 | 2022 | 210 | 0.870 |
Why?
|
| Pulmonary Fibrosis | 6 | 2022 | 157 | 0.840 |
Why?
|
| Myocardium | 15 | 2022 | 1204 | 0.820 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 10 | 2012 | 36 | 0.780 |
Why?
|
| Cell Adhesion Molecules | 24 | 2014 | 199 | 0.730 |
Why?
|
| Bleomycin | 6 | 2022 | 67 | 0.710 |
Why?
|
| Chick Embryo | 39 | 2014 | 379 | 0.710 |
Why?
|
| Cell Adhesion | 27 | 2014 | 324 | 0.670 |
Why?
|
| Kidney | 2 | 2021 | 945 | 0.660 |
Why?
|
| Extracellular Matrix Proteins | 9 | 2014 | 144 | 0.650 |
Why?
|
| Nerve Tissue Proteins | 12 | 2012 | 290 | 0.590 |
Why?
|
| Animals | 77 | 2022 | 20881 | 0.560 |
Why?
|
| Cell Movement | 18 | 2022 | 630 | 0.550 |
Why?
|
| Protein Kinase C | 5 | 2010 | 270 | 0.540 |
Why?
|
| Mice | 31 | 2022 | 8474 | 0.520 |
Why?
|
| Aging | 2 | 2021 | 911 | 0.510 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 8 | 1995 | 14 | 0.500 |
Why?
|
| Infusion Pumps | 1 | 2014 | 39 | 0.460 |
Why?
|
| Peptide Fragments | 11 | 2018 | 483 | 0.450 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2014 | 82 | 0.450 |
Why?
|
| Versicans | 9 | 2013 | 44 | 0.440 |
Why?
|
| Asthma | 2 | 2016 | 345 | 0.420 |
Why?
|
| Bronchi | 1 | 2012 | 59 | 0.420 |
Why?
|
| Drug Delivery Systems | 1 | 2014 | 236 | 0.400 |
Why?
|
| Tenascin | 19 | 2008 | 39 | 0.380 |
Why?
|
| Fibrosis | 6 | 2022 | 371 | 0.380 |
Why?
|
| Epithelial Cells | 2 | 2016 | 431 | 0.380 |
Why?
|
| Cells, Cultured | 15 | 2022 | 2673 | 0.370 |
Why?
|
| Signal Transduction | 13 | 2018 | 2689 | 0.350 |
Why?
|
| Neovascularization, Physiologic | 2 | 2009 | 164 | 0.350 |
Why?
|
| Extracellular Matrix | 12 | 2007 | 493 | 0.350 |
Why?
|
| Leukocytes | 1 | 2010 | 99 | 0.350 |
Why?
|
| Mesoderm | 10 | 2013 | 231 | 0.340 |
Why?
|
| Health Status Disparities | 1 | 2012 | 326 | 0.330 |
Why?
|
| ADAM Proteins | 1 | 2009 | 53 | 0.320 |
Why?
|
| Mice, Inbred C57BL | 8 | 2021 | 2791 | 0.320 |
Why?
|
| Antigens, Surface | 10 | 1989 | 71 | 0.310 |
Why?
|
| Collagen | 4 | 2008 | 636 | 0.310 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2008 | 175 | 0.300 |
Why?
|
| Amino Acid Sequence | 9 | 2021 | 1083 | 0.300 |
Why?
|
| Glycoproteins | 12 | 1989 | 238 | 0.290 |
Why?
|
| Curcumin | 2 | 2005 | 23 | 0.290 |
Why?
|
| Embryonic Development | 5 | 2008 | 100 | 0.290 |
Why?
|
| Chondrogenesis | 5 | 2008 | 15 | 0.280 |
Why?
|
| Heart Valves | 4 | 2014 | 171 | 0.260 |
Why?
|
| Endothelial Cells | 1 | 2009 | 384 | 0.260 |
Why?
|
| Caveolins | 1 | 2005 | 6 | 0.250 |
Why?
|
| RNA, Messenger | 12 | 2013 | 1664 | 0.250 |
Why?
|
| Eosinophils | 2 | 1996 | 60 | 0.250 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2005 | 82 | 0.240 |
Why?
|
| Hyaluronic Acid | 4 | 2014 | 206 | 0.240 |
Why?
|
| Embryo, Nonmammalian | 3 | 2003 | 64 | 0.240 |
Why?
|
| Blood Vessels | 2 | 2005 | 102 | 0.230 |
Why?
|
| Quail | 1 | 2003 | 27 | 0.220 |
Why?
|
| Laminin | 5 | 2012 | 62 | 0.220 |
Why?
|
| Endocardium | 4 | 2006 | 101 | 0.220 |
Why?
|
| Neurons | 11 | 2012 | 881 | 0.220 |
Why?
|
| Protein-Tyrosine Kinases | 3 | 2021 | 195 | 0.220 |
Why?
|
| Disease Models, Animal | 6 | 2017 | 2550 | 0.210 |
Why?
|
| Lectins, C-Type | 7 | 2005 | 39 | 0.210 |
Why?
|
| Transforming Growth Factor beta1 | 2 | 2013 | 126 | 0.210 |
Why?
|
| Neuroglia | 7 | 2010 | 136 | 0.200 |
Why?
|
| Cell Membrane | 11 | 2012 | 525 | 0.200 |
Why?
|
| Gene Expression Regulation, Developmental | 6 | 2008 | 328 | 0.200 |
Why?
|
| Humans | 33 | 2022 | 68618 | 0.190 |
Why?
|
| Male | 15 | 2022 | 37321 | 0.190 |
Why?
|
| Endocardial Cushions | 2 | 2013 | 20 | 0.190 |
Why?
|
| Immunohistochemistry | 7 | 2008 | 1174 | 0.190 |
Why?
|
| Skin Diseases | 1 | 2022 | 122 | 0.180 |
Why?
|
| Carrier Proteins | 3 | 1994 | 597 | 0.180 |
Why?
|
| MAP Kinase Signaling System | 4 | 2014 | 247 | 0.180 |
Why?
|
| In Vitro Techniques | 7 | 2014 | 765 | 0.180 |
Why?
|
| Heart Ventricles | 3 | 2022 | 738 | 0.170 |
Why?
|
| Chondroitin Sulfates | 2 | 1999 | 44 | 0.170 |
Why?
|
| Cell Proliferation | 6 | 2022 | 1174 | 0.170 |
Why?
|
| Transforming Growth Factor beta | 3 | 2014 | 384 | 0.160 |
Why?
|
| Receptors, Cell Surface | 2 | 2000 | 248 | 0.160 |
Why?
|
| Biomarkers | 3 | 2022 | 1593 | 0.160 |
Why?
|
| Cell Differentiation | 8 | 2014 | 1034 | 0.150 |
Why?
|
| Angiotensin II | 1 | 2018 | 220 | 0.150 |
Why?
|
| Brain | 12 | 2000 | 2176 | 0.150 |
Why?
|
| Collagen Type II | 3 | 2007 | 13 | 0.150 |
Why?
|
| Limb Buds | 2 | 2008 | 8 | 0.140 |
Why?
|
| Cadherins | 4 | 2000 | 93 | 0.140 |
Why?
|
| Female | 10 | 2022 | 38074 | 0.140 |
Why?
|
| Epitopes | 5 | 2001 | 146 | 0.140 |
Why?
|
| Isoenzymes | 3 | 2005 | 308 | 0.140 |
Why?
|
| Ventricular Function | 1 | 2017 | 93 | 0.140 |
Why?
|
| Fluorescent Antibody Technique | 5 | 2014 | 282 | 0.130 |
Why?
|
| Antigens | 4 | 1983 | 90 | 0.130 |
Why?
|
| I-kappa B Kinase | 1 | 2016 | 40 | 0.130 |
Why?
|
| Actins | 4 | 2013 | 249 | 0.130 |
Why?
|
| Protein Kinase C-epsilon | 3 | 2005 | 28 | 0.130 |
Why?
|
| Glutathione S-Transferase pi | 1 | 2016 | 53 | 0.130 |
Why?
|
| Hepatocyte Growth Factor | 2 | 2013 | 63 | 0.130 |
Why?
|
| Bone Morphogenetic Protein 2 | 2 | 2013 | 57 | 0.130 |
Why?
|
| Aggrecans | 3 | 2007 | 13 | 0.130 |
Why?
|
| Molecular Sequence Data | 8 | 2006 | 1447 | 0.130 |
Why?
|
| Gene Expression | 6 | 2017 | 770 | 0.120 |
Why?
|
| Nerve Regeneration | 2 | 2012 | 42 | 0.120 |
Why?
|
| Immunoenzyme Techniques | 2 | 2014 | 196 | 0.120 |
Why?
|
| Neurocan | 4 | 2003 | 6 | 0.120 |
Why?
|
| Molecular Weight | 14 | 1990 | 358 | 0.120 |
Why?
|
| Osmosis | 1 | 2014 | 38 | 0.120 |
Why?
|
| Pulmonary Alveoli | 1 | 2014 | 62 | 0.110 |
Why?
|
| Dictyostelium | 3 | 1978 | 7 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2013 | 33 | 0.110 |
Why?
|
| Blotting, Western | 4 | 2017 | 954 | 0.110 |
Why?
|
| Heart Failure | 1 | 2022 | 1180 | 0.110 |
Why?
|
| Hyaluronan Receptors | 1 | 2013 | 142 | 0.110 |
Why?
|
| Peripheral Nervous System | 1 | 2012 | 12 | 0.100 |
Why?
|
| Collagen Type I | 4 | 2017 | 175 | 0.100 |
Why?
|
| Hypertension | 1 | 2022 | 1535 | 0.100 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2013 | 135 | 0.100 |
Why?
|
| PPAR gamma | 1 | 2012 | 95 | 0.100 |
Why?
|
| Cathepsin B | 1 | 2012 | 33 | 0.100 |
Why?
|
| Proto-Oncogene Protein c-ets-1 | 1 | 2012 | 65 | 0.100 |
Why?
|
| Disease Susceptibility | 1 | 2012 | 179 | 0.100 |
Why?
|
| Integrin beta1 | 3 | 2001 | 48 | 0.100 |
Why?
|
| Weight Loss | 1 | 2014 | 319 | 0.100 |
Why?
|
| Integrins | 2 | 2014 | 115 | 0.100 |
Why?
|
| Acid Ceramidase | 1 | 2012 | 85 | 0.100 |
Why?
|
| Embryo, Mammalian | 4 | 2005 | 176 | 0.090 |
Why?
|
| Apoptosis | 3 | 2008 | 1641 | 0.090 |
Why?
|
| Neoplasm Invasiveness | 1 | 2012 | 369 | 0.090 |
Why?
|
| Lysophospholipids | 1 | 2012 | 209 | 0.090 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2014 | 223 | 0.090 |
Why?
|
| Mice, Inbred Strains | 2 | 2008 | 181 | 0.090 |
Why?
|
| Gene Expression Regulation | 3 | 2013 | 1293 | 0.090 |
Why?
|
| Neutrophil Infiltration | 1 | 2010 | 35 | 0.090 |
Why?
|
| Bone Morphogenetic Proteins | 2 | 2007 | 43 | 0.090 |
Why?
|
| Chemotaxis, Leukocyte | 2 | 2001 | 48 | 0.090 |
Why?
|
| Sphingosine | 1 | 2012 | 315 | 0.090 |
Why?
|
| Cell Nucleus | 3 | 2013 | 305 | 0.090 |
Why?
|
| Protein Binding | 9 | 2007 | 1027 | 0.090 |
Why?
|
| Triazines | 1 | 2010 | 48 | 0.090 |
Why?
|
| Inflammation | 1 | 2016 | 1030 | 0.090 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2010 | 116 | 0.080 |
Why?
|
| Neutrophils | 2 | 2001 | 204 | 0.080 |
Why?
|
| Umbilical Cord | 1 | 2009 | 19 | 0.080 |
Why?
|
| ADAM17 Protein | 1 | 2009 | 28 | 0.080 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2012 | 786 | 0.080 |
Why?
|
| Nervous System | 5 | 2005 | 45 | 0.080 |
Why?
|
| Cell Lineage | 1 | 2009 | 146 | 0.080 |
Why?
|
| Up-Regulation | 4 | 2012 | 682 | 0.080 |
Why?
|
| Gene Silencing | 1 | 2009 | 137 | 0.080 |
Why?
|
| Myxomycetes | 2 | 1978 | 2 | 0.080 |
Why?
|
| Extremities | 2 | 2005 | 49 | 0.080 |
Why?
|
| Membrane Proteins | 3 | 2004 | 617 | 0.080 |
Why?
|
| Gene Knockdown Techniques | 1 | 2009 | 196 | 0.080 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2009 | 145 | 0.080 |
Why?
|
| Embryonic and Fetal Development | 4 | 1995 | 74 | 0.080 |
Why?
|
| Microscopy, Confocal | 4 | 2007 | 337 | 0.080 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2008 | 34 | 0.080 |
Why?
|
| Public Health Nursing | 1 | 1987 | 7 | 0.080 |
Why?
|
| In Situ Hybridization | 3 | 2007 | 201 | 0.080 |
Why?
|
| Atrioventricular Node | 1 | 2008 | 39 | 0.080 |
Why?
|
| Brain Chemistry | 2 | 1992 | 173 | 0.070 |
Why?
|
| Oligonucleotides, Antisense | 2 | 2005 | 48 | 0.070 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2009 | 219 | 0.070 |
Why?
|
| Antibodies, Monoclonal | 8 | 2001 | 511 | 0.070 |
Why?
|
| Joints | 1 | 2007 | 30 | 0.070 |
Why?
|
| Homeodomain Proteins | 2 | 2005 | 157 | 0.070 |
Why?
|
| Connective Tissue | 1 | 2007 | 61 | 0.070 |
Why?
|
| Fibrillar Collagens | 1 | 2007 | 49 | 0.070 |
Why?
|
| Sphingolipids | 1 | 2010 | 337 | 0.070 |
Why?
|
| Home Care Services | 1 | 1987 | 84 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2017 | 710 | 0.070 |
Why?
|
| Endocardial Cushion Defects | 1 | 2006 | 11 | 0.070 |
Why?
|
| Fibronectins | 5 | 2017 | 130 | 0.070 |
Why?
|
| Oxidative Stress | 2 | 2016 | 718 | 0.070 |
Why?
|
| Morphogenesis | 6 | 2005 | 159 | 0.070 |
Why?
|
| Nuchal Translucency Measurement | 1 | 2005 | 1 | 0.070 |
Why?
|
| Neural Cell Adhesion Molecules | 1 | 2005 | 3 | 0.070 |
Why?
|
| Trichloroethylene | 1 | 2006 | 41 | 0.070 |
Why?
|
| Cytoskeletal Proteins | 2 | 1997 | 108 | 0.070 |
Why?
|
| Calcium-Binding Proteins | 1 | 2006 | 114 | 0.070 |
Why?
|
| Protein Processing, Post-Translational | 3 | 2016 | 284 | 0.070 |
Why?
|
| Prostatic Neoplasms | 1 | 2012 | 778 | 0.070 |
Why?
|
| Trisomy | 1 | 2005 | 47 | 0.070 |
Why?
|
| Microfilament Proteins | 1 | 2006 | 102 | 0.070 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2006 | 216 | 0.060 |
Why?
|
| Trans-Activators | 2 | 1997 | 237 | 0.060 |
Why?
|
| Cerebellum | 3 | 2012 | 103 | 0.060 |
Why?
|
| Nerve Tissue | 1 | 2005 | 6 | 0.060 |
Why?
|
| Mutation | 6 | 2010 | 1213 | 0.060 |
Why?
|
| Butadienes | 1 | 2005 | 26 | 0.060 |
Why?
|
| Chickens | 6 | 2007 | 232 | 0.060 |
Why?
|
| Musculoskeletal System | 1 | 2005 | 11 | 0.060 |
Why?
|
| Protein Kinase C-alpha | 1 | 2005 | 24 | 0.060 |
Why?
|
| Retina | 5 | 2000 | 252 | 0.060 |
Why?
|
| Enzyme Activation | 2 | 2005 | 791 | 0.060 |
Why?
|
| Nitriles | 1 | 2005 | 68 | 0.060 |
Why?
|
| Models, Theoretical | 1 | 1987 | 384 | 0.060 |
Why?
|
| Head and Neck Neoplasms | 1 | 2010 | 561 | 0.060 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 2 | 2005 | 95 | 0.060 |
Why?
|
| Flow Cytometry | 2 | 2017 | 489 | 0.060 |
Why?
|
| Tooth | 1 | 2004 | 24 | 0.060 |
Why?
|
| Case-Control Studies | 2 | 2022 | 1553 | 0.060 |
Why?
|
| Heme Oxygenase (Decyclizing) | 1 | 2004 | 11 | 0.060 |
Why?
|
| Stress Fibers | 1 | 2004 | 10 | 0.060 |
Why?
|
| Biological Evolution | 1 | 1984 | 86 | 0.060 |
Why?
|
| Cell Size | 1 | 2004 | 76 | 0.060 |
Why?
|
| Heme Oxygenase-1 | 1 | 2004 | 40 | 0.060 |
Why?
|
| Receptors, CXCR4 | 2 | 2014 | 48 | 0.060 |
Why?
|
| Enzyme Inhibitors | 2 | 2005 | 659 | 0.060 |
Why?
|
| Transferases (Other Substituted Phosphate Groups) | 3 | 2000 | 15 | 0.060 |
Why?
|
| Interleukin-8 | 2 | 2001 | 71 | 0.060 |
Why?
|
| Aged | 3 | 2022 | 14862 | 0.060 |
Why?
|
| Transfection | 2 | 2004 | 782 | 0.060 |
Why?
|
| Body Patterning | 1 | 2003 | 44 | 0.050 |
Why?
|
| Base Sequence | 6 | 2007 | 1015 | 0.050 |
Why?
|
| Forelimb | 1 | 2003 | 15 | 0.050 |
Why?
|
| Drug Resistance | 1 | 2004 | 223 | 0.050 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 2 | 2001 | 7 | 0.050 |
Why?
|
| Leukotriene B4 | 2 | 2001 | 17 | 0.050 |
Why?
|
| Thrombin | 2 | 2001 | 117 | 0.050 |
Why?
|
| Glutathione Transferase | 1 | 2004 | 166 | 0.050 |
Why?
|
| Tissue Culture Techniques | 1 | 2003 | 62 | 0.050 |
Why?
|
| Young Adult | 2 | 2013 | 5717 | 0.050 |
Why?
|
| Organ Culture Techniques | 2 | 2017 | 122 | 0.050 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2005 | 306 | 0.050 |
Why?
|
| Cell Line | 3 | 2016 | 1752 | 0.050 |
Why?
|
| Down-Regulation | 1 | 2004 | 447 | 0.050 |
Why?
|
| Adenoviridae | 3 | 2007 | 295 | 0.050 |
Why?
|
| Exons | 2 | 1995 | 122 | 0.050 |
Why?
|
| Mental Disorders | 1 | 1987 | 659 | 0.050 |
Why?
|
| Receptors, Fibronectin | 1 | 2001 | 6 | 0.050 |
Why?
|
| Cell Migration Inhibition | 1 | 2001 | 8 | 0.050 |
Why?
|
| Neurites | 2 | 2012 | 18 | 0.050 |
Why?
|
| Middle Aged | 3 | 2022 | 21147 | 0.050 |
Why?
|
| Endothelium, Vascular | 1 | 2003 | 371 | 0.050 |
Why?
|
| Immunologic Techniques | 4 | 1989 | 30 | 0.050 |
Why?
|
| Sialic Acids | 4 | 1984 | 27 | 0.050 |
Why?
|
| Cell Aggregation | 6 | 1990 | 28 | 0.050 |
Why?
|
| Heart Atria | 3 | 2009 | 206 | 0.040 |
Why?
|
| Neuraminidase | 2 | 1995 | 36 | 0.040 |
Why?
|
| Receptor-Like Protein Tyrosine Phosphatases, Class 5 | 1 | 1999 | 2 | 0.040 |
Why?
|
| Time Factors | 4 | 2006 | 4655 | 0.040 |
Why?
|
| Fibrin | 1 | 1999 | 35 | 0.040 |
Why?
|
| Notochord | 1 | 1998 | 1 | 0.040 |
Why?
|
| Angiotensins | 1 | 2018 | 16 | 0.040 |
Why?
|
| Mice, Knockout | 3 | 2008 | 1692 | 0.040 |
Why?
|
| Capillary Permeability | 1 | 2018 | 69 | 0.040 |
Why?
|
| RNA | 1 | 1999 | 171 | 0.040 |
Why?
|
| Evaluation Studies as Topic | 2 | 1995 | 219 | 0.040 |
Why?
|
| Renin-Angiotensin System | 1 | 2018 | 79 | 0.040 |
Why?
|
| Bone Marrow Cells | 1 | 2018 | 217 | 0.040 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2018 | 140 | 0.040 |
Why?
|
| Cytoskeleton | 2 | 2014 | 84 | 0.040 |
Why?
|
| Membrane Glycoproteins | 2 | 1991 | 370 | 0.040 |
Why?
|
| Mice, Transgenic | 3 | 2005 | 1033 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2013 | 507 | 0.040 |
Why?
|
| Infusion Pumps, Implantable | 1 | 2017 | 26 | 0.040 |
Why?
|
| Scleroderma, Localized | 1 | 2017 | 19 | 0.040 |
Why?
|
| HSP47 Heat-Shock Proteins | 1 | 2017 | 2 | 0.040 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2017 | 76 | 0.040 |
Why?
|
| Focal Adhesion Kinase 2 | 1 | 2017 | 18 | 0.040 |
Why?
|
| Leukocyte Common Antigens | 1 | 2017 | 41 | 0.040 |
Why?
|
| Adult | 3 | 2013 | 21403 | 0.040 |
Why?
|
| Phalloidine | 1 | 1996 | 5 | 0.040 |
Why?
|
| Interleukin-4 | 1 | 1996 | 69 | 0.030 |
Why?
|
| Integrin beta3 | 1 | 2017 | 35 | 0.030 |
Why?
|
| Prognosis | 1 | 2022 | 2093 | 0.030 |
Why?
|
| src-Family Kinases | 1 | 2017 | 91 | 0.030 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 1996 | 56 | 0.030 |
Why?
|
| Glutaredoxins | 1 | 2016 | 12 | 0.030 |
Why?
|
| Pressure | 1 | 2017 | 252 | 0.030 |
Why?
|
| Constriction, Pathologic | 1 | 2017 | 236 | 0.030 |
Why?
|
| Gravitation | 1 | 1995 | 12 | 0.030 |
Why?
|
| Centrifugation | 1 | 1995 | 16 | 0.030 |
Why?
|
| Cattle | 2 | 1994 | 475 | 0.030 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2017 | 102 | 0.030 |
Why?
|
| N-Acetylgalactosaminyltransferases | 1 | 1995 | 2 | 0.030 |
Why?
|
| Peptides | 2 | 1995 | 455 | 0.030 |
Why?
|
| Rats | 3 | 2010 | 5300 | 0.030 |
Why?
|
| Aorta | 1 | 2017 | 316 | 0.030 |
Why?
|
| Phosphatidylinositol Diacylglycerol-Lyase | 1 | 1995 | 6 | 0.030 |
Why?
|
| Peptide Mapping | 1 | 1995 | 39 | 0.030 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 1995 | 22 | 0.030 |
Why?
|
| Protein Structure, Secondary | 1 | 1995 | 136 | 0.030 |
Why?
|
| Organ Specificity | 1 | 1995 | 167 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 1995 | 93 | 0.030 |
Why?
|
| Health Facility Environment | 1 | 1994 | 11 | 0.030 |
Why?
|
| Personnel, Hospital | 1 | 1994 | 19 | 0.030 |
Why?
|
| Information Services | 1 | 1994 | 22 | 0.030 |
Why?
|
| Receptors, Antigen | 1 | 1994 | 6 | 0.030 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2014 | 27 | 0.030 |
Why?
|
| Intercellular Junctions | 1 | 1994 | 32 | 0.030 |
Why?
|
| DNA Primers | 2 | 2007 | 302 | 0.030 |
Why?
|
| Protein Isoforms | 2 | 2005 | 246 | 0.030 |
Why?
|
| NF-kappa B | 1 | 2016 | 432 | 0.030 |
Why?
|
| Lipopolysaccharides | 1 | 2016 | 455 | 0.030 |
Why?
|
| Matrix Attachment Regions | 1 | 2013 | 4 | 0.030 |
Why?
|
| Receptors, Laminin | 1 | 1993 | 4 | 0.030 |
Why?
|
| Glucuronosyltransferase | 1 | 2013 | 38 | 0.030 |
Why?
|
| Interleukin-5 | 1 | 1993 | 14 | 0.030 |
Why?
|
| Autocrine Communication | 1 | 2013 | 37 | 0.030 |
Why?
|
| Hospital Administration | 1 | 1994 | 43 | 0.030 |
Why?
|
| Neural Crest | 3 | 1990 | 58 | 0.030 |
Why?
|
| Sheep | 1 | 2014 | 128 | 0.030 |
Why?
|
| Smad3 Protein | 1 | 2013 | 33 | 0.030 |
Why?
|
| Culture Media | 1 | 2013 | 155 | 0.030 |
Why?
|
| Efficiency, Organizational | 1 | 1994 | 61 | 0.030 |
Why?
|
| Smad2 Protein | 1 | 2013 | 42 | 0.030 |
Why?
|
| Diffusion of Innovation | 1 | 1994 | 102 | 0.030 |
Why?
|
| Eosinophilia | 1 | 1993 | 47 | 0.030 |
Why?
|
| Immunoglobulin Fab Fragments | 2 | 2001 | 48 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2013 | 209 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2014 | 235 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 1 | 2013 | 322 | 0.030 |
Why?
|
| RNA Interference | 1 | 2013 | 266 | 0.030 |
Why?
|
| Phosphorylation | 4 | 2000 | 1200 | 0.030 |
Why?
|
| RNA Splicing | 2 | 1989 | 32 | 0.030 |
Why?
|
| Microarray Analysis | 1 | 2012 | 63 | 0.030 |
Why?
|
| Species Specificity | 3 | 1992 | 303 | 0.030 |
Why?
|
| DNA, Complementary | 1 | 2012 | 251 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2014 | 331 | 0.020 |
Why?
|
| Microscopy, Phase-Contrast | 1 | 1991 | 13 | 0.020 |
Why?
|
| Neoplasm Proteins | 1 | 1994 | 307 | 0.020 |
Why?
|
| Microscopy, Electron | 2 | 1989 | 351 | 0.020 |
Why?
|
| Ligands | 4 | 1996 | 317 | 0.020 |
Why?
|
| Bromodeoxyuridine | 1 | 2010 | 37 | 0.020 |
Why?
|
| Sarcomeres | 1 | 2010 | 32 | 0.020 |
Why?
|
| Computational Biology | 1 | 2012 | 190 | 0.020 |
Why?
|
| Attitude of Health Personnel | 1 | 1994 | 442 | 0.020 |
Why?
|
| Losartan | 1 | 2010 | 45 | 0.020 |
Why?
|
| Cell Survival | 1 | 1993 | 901 | 0.020 |
Why?
|
| CD18 Antigens | 2 | 2001 | 9 | 0.020 |
Why?
|
| Nerve Crush | 1 | 2010 | 1 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2006 | 1745 | 0.020 |
Why?
|
| Carbohydrates | 2 | 1982 | 57 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2012 | 615 | 0.020 |
Why?
|
| Somatosensory Cortex | 1 | 1989 | 22 | 0.020 |
Why?
|
| Optic Nerve | 1 | 2010 | 55 | 0.020 |
Why?
|
| High-Throughput Screening Assays | 1 | 2010 | 48 | 0.020 |
Why?
|
| Skin | 2 | 2007 | 451 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 1982 | 272 | 0.020 |
Why?
|
| Myelin Sheath | 1 | 2010 | 115 | 0.020 |
Why?
|
| Cyclic AMP | 1 | 2010 | 223 | 0.020 |
Why?
|
| Transforming Growth Factor beta3 | 1 | 2009 | 16 | 0.020 |
Why?
|
| Regeneration | 1 | 2010 | 105 | 0.020 |
Why?
|
| Phenotype | 1 | 2012 | 947 | 0.020 |
Why?
|
| Binding Sites | 2 | 2007 | 631 | 0.020 |
Why?
|
| Axons | 1 | 2010 | 139 | 0.020 |
Why?
|
| Spinal Cord | 1 | 2010 | 244 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2010 | 2083 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 2 | 1992 | 532 | 0.020 |
Why?
|
| Muscles | 1 | 1988 | 158 | 0.020 |
Why?
|
| ErbB Receptors | 1 | 2010 | 239 | 0.020 |
Why?
|
| Glycoconjugates | 1 | 1988 | 22 | 0.020 |
Why?
|
| Alcian Blue | 1 | 2008 | 5 | 0.020 |
Why?
|
| Inhibitor of Differentiation Protein 1 | 1 | 2007 | 7 | 0.020 |
Why?
|
| Twist-Related Protein 1 | 1 | 2007 | 13 | 0.020 |
Why?
|
| Smad Proteins | 1 | 2007 | 25 | 0.020 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type I | 1 | 2007 | 12 | 0.020 |
Why?
|
| Avian Proteins | 1 | 2007 | 23 | 0.020 |
Why?
|
| Anthraquinones | 1 | 2008 | 18 | 0.020 |
Why?
|
| Taiwan | 1 | 1987 | 20 | 0.020 |
Why?
|
| Pronase | 2 | 1978 | 5 | 0.020 |
Why?
|
| Microscopy, Atomic Force | 1 | 2008 | 66 | 0.020 |
Why?
|
| Cartilage | 1 | 1988 | 51 | 0.020 |
Why?
|
| Embryonic Stem Cells | 1 | 2007 | 40 | 0.020 |
Why?
|
| Cycloheximide | 2 | 1996 | 50 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2008 | 160 | 0.020 |
Why?
|
| Structure-Activity Relationship | 4 | 1990 | 420 | 0.020 |
Why?
|
| Calorimetry, Differential Scanning | 1 | 2007 | 27 | 0.020 |
Why?
|
| Stem Cells | 1 | 2009 | 248 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2012 | 1851 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2007 | 127 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2007 | 132 | 0.020 |
Why?
|
| Myocytes, Cardiac | 1 | 2010 | 442 | 0.020 |
Why?
|
| Microinjections | 1 | 2007 | 130 | 0.020 |
Why?
|
| Cerebral Cortex | 1 | 2010 | 415 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2007 | 200 | 0.020 |
Why?
|
| Aftercare | 1 | 1987 | 114 | 0.020 |
Why?
|
| rho-Associated Kinases | 1 | 2006 | 32 | 0.020 |
Why?
|
| Coturnix | 1 | 2006 | 22 | 0.020 |
Why?
|
| Ganglia, Spinal | 1 | 1986 | 29 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2001 | 626 | 0.020 |
Why?
|
| beta Catenin | 2 | 1997 | 73 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2007 | 161 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2007 | 320 | 0.020 |
Why?
|
| Age Factors | 3 | 1989 | 1864 | 0.020 |
Why?
|
| Biomechanical Phenomena | 1 | 2007 | 368 | 0.020 |
Why?
|
| Transcriptional Activation | 2 | 1997 | 226 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 1994 | 2800 | 0.020 |
Why?
|
| Fetal Heart | 1 | 2005 | 41 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2005 | 166 | 0.020 |
Why?
|
| Immune Sera | 2 | 2001 | 30 | 0.020 |
Why?
|
| Neck | 1 | 2005 | 62 | 0.020 |
Why?
|
| Matrix Metalloproteinases | 1 | 2007 | 223 | 0.020 |
Why?
|
| Diarylheptanoids | 1 | 2005 | 3 | 0.020 |
Why?
|
| Myosin Light Chains | 1 | 2005 | 18 | 0.020 |
Why?
|
| Cloning, Molecular | 2 | 2000 | 357 | 0.020 |
Why?
|
| Cardiac Myosins | 1 | 2005 | 12 | 0.020 |
Why?
|
| Larva | 1 | 1984 | 39 | 0.020 |
Why?
|
| Sulfates | 1 | 1984 | 28 | 0.020 |
Why?
|
| Xenopus laevis | 1 | 1984 | 60 | 0.020 |
Why?
|
| Phosphates | 1 | 1984 | 72 | 0.020 |
Why?
|
| Odontoblasts | 1 | 2004 | 3 | 0.010 |
Why?
|
| MSX1 Transcription Factor | 1 | 2004 | 9 | 0.010 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2004 | 17 | 0.010 |
Why?
|
| Molar | 1 | 2004 | 27 | 0.010 |
Why?
|
| Risk Factors | 1 | 2014 | 5731 | 0.010 |
Why?
|
| Epithelium | 1 | 2004 | 172 | 0.010 |
Why?
|
| Antibodies | 2 | 1999 | 241 | 0.010 |
Why?
|
| Aorta, Thoracic | 1 | 2005 | 211 | 0.010 |
Why?
|
| Models, Biological | 1 | 2007 | 981 | 0.010 |
Why?
|
| Sialoglycoproteins | 1 | 1983 | 24 | 0.010 |
Why?
|
| Chromatography, DEAE-Cellulose | 1 | 1982 | 14 | 0.010 |
Why?
|
| Chromatography, Gel | 1 | 1982 | 79 | 0.010 |
Why?
|
| Amino Acids | 1 | 1982 | 131 | 0.010 |
Why?
|
| Kinetics | 1 | 1983 | 1047 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2001 | 189 | 0.010 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2001 | 117 | 0.010 |
Why?
|
| Adolescent | 1 | 2013 | 8912 | 0.010 |
Why?
|
| Oligopeptides | 1 | 2001 | 152 | 0.010 |
Why?
|
| Drug Combinations | 1 | 2001 | 304 | 0.010 |
Why?
|
| Receptors, Thrombin | 1 | 2000 | 18 | 0.010 |
Why?
|
| Chemotaxis | 1 | 2000 | 38 | 0.010 |
Why?
|
| Culture Media, Conditioned | 1 | 2000 | 78 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2004 | 700 | 0.010 |
Why?
|
| Hydrolysis | 1 | 2000 | 144 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2004 | 753 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 2001 | 397 | 0.010 |
Why?
|
| Chondroitinases and Chondroitin Lyases | 1 | 1999 | 6 | 0.010 |
Why?
|
| Cell Division | 1 | 2000 | 541 | 0.010 |
Why?
|
| Hyaluronoglucosaminidase | 1 | 1999 | 43 | 0.010 |
Why?
|
| Antibody Specificity | 1 | 1999 | 98 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1999 | 138 | 0.010 |
Why?
|
| Glycosaminoglycans | 1 | 1999 | 88 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 1989 | 95 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 2001 | 481 | 0.010 |
Why?
|
| Receptors, Concanavalin A | 1 | 1978 | 1 | 0.010 |
Why?
|
| Monosaccharides | 1 | 1978 | 4 | 0.010 |
Why?
|
| Glycolipids | 1 | 1978 | 20 | 0.010 |
Why?
|
| Antigens, Fungal | 1 | 1978 | 19 | 0.010 |
Why?
|
| Biochemistry | 1 | 1977 | 12 | 0.010 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 1977 | 67 | 0.010 |
Why?
|
| Dactinomycin | 1 | 1996 | 31 | 0.010 |
Why?
|
| Intracellular Membranes | 1 | 1977 | 86 | 0.010 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 1996 | 32 | 0.010 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 1996 | 45 | 0.010 |
Why?
|
| Rifabutin | 1 | 1996 | 5 | 0.010 |
Why?
|
| Lactams, Macrocyclic | 1 | 1996 | 7 | 0.010 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 1996 | 48 | 0.010 |
Why?
|
| Arsenicals | 1 | 1996 | 8 | 0.010 |
Why?
|
| Cell Fractionation | 1 | 1996 | 34 | 0.010 |
Why?
|
| Quinones | 1 | 1996 | 13 | 0.010 |
Why?
|
| Benzoquinones | 1 | 1996 | 13 | 0.010 |
Why?
|
| Interleukin-1 | 1 | 1996 | 86 | 0.010 |
Why?
|
| Genistein | 1 | 1996 | 26 | 0.010 |
Why?
|
| Isoflavones | 1 | 1996 | 31 | 0.010 |
Why?
|
| DNA | 2 | 1989 | 597 | 0.010 |
Why?
|
| Interferon-gamma | 1 | 1996 | 241 | 0.010 |
Why?
|
| Tissue Distribution | 2 | 1986 | 282 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 1995 | 165 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 1996 | 330 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 1995 | 234 | 0.010 |
Why?
|
| Organizational Culture | 1 | 1994 | 59 | 0.010 |
Why?
|
| Factor Analysis, Statistical | 1 | 1994 | 201 | 0.010 |
Why?
|
| Immunochemistry | 1 | 1992 | 17 | 0.010 |
Why?
|
| Tunicamycin | 1 | 1992 | 10 | 0.010 |
Why?
|
| Fear | 1 | 1994 | 239 | 0.010 |
Why?
|
| Antigen-Antibody Complex | 2 | 1984 | 175 | 0.010 |
Why?
|
| Mitochondria | 1 | 1977 | 643 | 0.010 |
Why?
|
| Psychometrics | 1 | 1994 | 514 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1992 | 852 | 0.010 |
Why?
|
| Swine | 1 | 1992 | 672 | 0.010 |
Why?
|
| Peripheral Nerves | 1 | 1989 | 22 | 0.010 |
Why?
|
| Endothelium | 1 | 1990 | 98 | 0.010 |
Why?
|
| Deoxyribonuclease EcoRI | 1 | 1989 | 6 | 0.010 |
Why?
|
| Cyanogen Bromide | 1 | 1989 | 14 | 0.010 |
Why?
|
| Introns | 1 | 1988 | 68 | 0.010 |
Why?
|
| Protein Precursors | 1 | 1989 | 105 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 1989 | 396 | 0.010 |
Why?
|
| Immunoglobulins | 1 | 1989 | 97 | 0.000 |
Why?
|
| Reproducibility of Results | 1 | 1994 | 2077 | 0.000 |
Why?
|
| Ganglia | 1 | 1987 | 6 | 0.000 |
Why?
|
| Fibrinogen | 1 | 1988 | 87 | 0.000 |
Why?
|
| Epidermal Growth Factor | 1 | 1988 | 95 | 0.000 |
Why?
|
| Protein Conformation | 1 | 1989 | 362 | 0.000 |
Why?
|
| Models, Molecular | 1 | 1989 | 546 | 0.000 |
Why?
|
| Gastrula | 1 | 1986 | 17 | 0.000 |
Why?
|
| Basement Membrane | 1 | 1986 | 48 | 0.000 |
Why?
|
| Cross Reactions | 1 | 1984 | 57 | 0.000 |
Why?
|
| Phosphothreonine | 1 | 1984 | 5 | 0.000 |
Why?
|
| Phosphoserine | 1 | 1984 | 14 | 0.000 |
Why?
|
| Glycopeptides | 1 | 1984 | 15 | 0.000 |
Why?
|
| Macromolecular Substances | 1 | 1983 | 122 | 0.000 |
Why?
|
| Peptide Hydrolases | 1 | 1983 | 82 | 0.000 |
Why?
|
| Gestational Age | 1 | 1983 | 389 | 0.000 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 1983 | 235 | 0.000 |
Why?
|
| Liposomes | 1 | 1982 | 107 | 0.000 |
Why?
|